bpc-157 for ulcerative colitis Post from Dr. Jones, DC JPP No 5/2013 article 09
JPP No 5 2013 article 09 Another step forward: The FDA Pharmacy Compounding Advisory Committee voted 86 in favor of recommending BPC 157 for ulcerative colitis. An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them
Pay in 4 interest-free payments of $5.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19


